Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder

A Pharmacoeconomic analysis of compliance gains on antipsychotic medications

(2013) Joep Damen et al.   Applied Health Economics and Health Policy

An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia

(2011) Giorgio Colombo   Neuropsychiatric Disease and Treatment

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Utility Assessment in Patients with Mental Disorders

(2009) Hans-Helmut König et al.   PHARMACOECONOMICS

The metabolic syndrome and schizophrenia

(2008) J. M. Meyer et al.   ACTA PSYCHIATRICA SCANDINAVICA

A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia

(2008) W. Wolfgang Fleischhacker et al.   BIOLOGICAL PSYCHIATRY

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics

(2008) Christoph U Correll et al.   BIPOLAR DISORDERS

Cost-effectiveness of atypical antipsychotics for the management of schizophrenia in the UK

(2008) Andrew Davies et al.   CURRENT MEDICAL RESEARCH AND OPINION

Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis

(2008) A.-B. Wirhn et al.   DIABETIC MEDICINE

Olanzapine Versus Aripiprazole for the Treatment of Agitation in Acutely Ill Patients With Schizophrenia

(2008) Bruce J. Kinon et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review

(2008) Marc De Hert et al.   SCHIZOPHRENIA RESEARCH